로딩 중…
지수 로딩 중…
Sinsin Pharmaceutical Co., Ltd
002800· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩3,965-0.25%
2026-11-02
Financials
Valuation Metrics
Sinsin Pharmaceutical Co., Ltd's Market Cap is ₩602B. At end of 2025 it was ₩889B. Ranked #1579 of 2,410 in KR market (top 66%), #927 of 1,631 on KOSDAQ (top 57%), #174 of 231 in Pharmaceuticals, Biotechnology & Life Sciences (top 75%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 60.15B KRW | KR#1,579/2,410 Sec#174/231 |
| Revenue | 123.05B KRW | KR#1,298/2,410 Sec#80/231 |
| Net Income | 13.40B KRW | KR#859/2,410 Sec#57/231 |
| Total Assets | 141.16B KRW | KR#1,554/2,410 Sec#120/231 |
| Net Assets | 78.74B KRW | KR#1,602/2,410 Sec#130/231 |
| Employees | 352 | KR#686/2,410 Sec#61/231 |
| Value | ||
| P/E | 4.49x | KR#346/2,410 Sec#12/231 |
| P/B | 0.76x | KR#1,290/2,410 Sec#76/231 |
| P/S | 0.49x | KR#964/2,410 Sec#45/231 |
| EV/EBITDA | 6.67x | KR#407/2,410 Sec#16/231 |
| FCF Yield | 11.59% | KR#588/2,410 Sec#20/231 |
| Profitability | ||
| ROE | 17.02% | KR#243/2,410 Sec#13/231 |
| ROA | 9.50% | KR#308/2,410 Sec#24/231 |
| Op. Margin | 11.81% | KR#429/2,410 Sec#37/231 |
| Revenue Growth | 14.86% | KR#691/2,410 Sec#66/231 |
| Financial Health | ||
| Debt Ratio | 79.28% | KR#1,336/2,410 Sec#157/231 |
| Total Debt | 39.84B KRW | KR#1,101/2,410 Sec#78/231 |
| FCF | 6.97B KRW | KR#816/2,410 Sec#51/231 |
| Cash | 2.98B KRW | KR#2,160/2,410 Sec#205/231 |
| Current Ratio | 1.07x | KR#1,639/2,410 Sec#163/231 |
| Net Debt/EBITDA | 2.54x | KR#877/2,410 Sec#63/231 |
| Dividend | ||
| Div. Yield | 2.02% | KR#923/2,410 Sec#45/231 |
| Div. Growth | 33.33% | KR#328/2,410 Sec#17/231 |
| Performance | ||
| 1Y Return | -24.48% | KR#1,252/2,410 Sec#90/231 |
| 1M Return | -11.00% | KR#1,343/2,410 Sec#134/231 |
| From 52W High | -43.28% | KR#868/2,410 Sec#61/231 |
| 1Y MDD | -40.20% | KR#596/2,410 Sec#40/231 |
| Trading | ||
| Volume | 8,169 shares | KR#1,263/2,410 Sec#127/231 |
| Trading Value | 32.4M KRW | KR#1,393/2,410 Sec#145/231 |
| Foreign Own. | 3.81% | KR#1,089/2,410 Sec#99/231 |
| Per Share | ||
| EPS | 884 KRW | KR#776/2,410 Sec#54/231 |
| BPS | 5,190 KRW | KR#1,480/2,410 Sec#105/231 |
Company Info
동사는 1959년 설립되어 2017년 코스닥에 상장된 외용제 OTC의약품 제조·판매 기업임. 첩부제, 에어로솔제, 액제 등을 생산하고 있으며, 파스, 물파스, 에어파스, 해충기피제, 외용액제 등을 포함한 약 100여 종의 OTC 의약품 및 의약외품을 생산하고 있음. 전국 주요 도시에 영업지점을 운영하며 1만2천여 소매약국과 직거래하고, OTC 영업 전문 인력 양성 프로그램을 통해 약국 직접 영업을 강화하고 있음. 신신제약는 1959년에 설립되었으며 세종특별자치시 소정면에 본사를 두고 있습니다.